Claims

Search Type State Status Topic Model Order Counting Over

As of snapshot 27745 under ledger-default@0.3.0.

Claim	Type	Assessment	Score	Review checks	References
The STEP analysis found no significant treatment-by-metabolic-syndrome interaction for cardiovascular or safety outcomes, although hypotension was numerically more frequent with intensive treatment in the highest tertile.	QUANTITATIVE	Supported	0.8808	1 of 4	168
Over a median 3.32-year follow-up, intensive systolic blood-pressure lowering was associated with lower primary cardiovascular-outcome risk than standard treatment across metabolic-syndrome tertiles; the largest reduction was in the middle tertile (HR 0.66, 95% CI 0.44–0.99).	QUANTITATIVE	Supported	0.8808	1 of 4	151
A post hoc STEP-trial analysis included 8,231 participants with complete metabolic-syndrome severity data and used an age-, sex-, and ethnicity-specific scoring model.	OBSERVATIONAL	Supported	0.8581	1 of 4	161